Faculty Articles

Title

Anticoagulation With Dabigatran: When to Worry

Publication Title

Medscape

Publication Date / Copyright Date

9-3-2015

Publisher

Medscape

Abstract

Dabigatran etexilate is the prodrug of dabigatran, a direct thrombin inhibitor that is used to reduce the risk for stroke and systemic embolism in patients with nonvalvular atrial fibrillation (NVAF) and to prevent and treat venous thromboembolism (VTE).

Disciplines

Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences

Keywords

anticoagulation, dabigatran, embolism, inhibitor, nonvalvular atrial fibrillation (NVAF) stroke

Find in your library

Share

 
COinS